Hahah ya, small-cap biotech is responsible for most of my brain damage. More of a medtech guy now by preference.
Could be interesting. With generic epipens now it's a pretty tough market, esp. to shake up new method of action. But with so many ppl having trypanophobia could find a nice niche if they can get it on shelves and have awareness.
Missing some important stock moves in >$1bn market cap space such as $SPRY yesterday. It's a shame since that part of your daily is very useful
Ya, can’t flag everything I’m afraid. Don’t know anything about them - like an Epipen comp? Upgrade from RayJ was bullish.
Got a lot of brain damage when I was a healthcare analyst and Mylan had that whole Epipen controversy. Bad memories…
Oh so you know that space… indeed they just got fda approval for a epipherine nasal spray. game changer really
Hahah ya, small-cap biotech is responsible for most of my brain damage. More of a medtech guy now by preference.
Could be interesting. With generic epipens now it's a pretty tough market, esp. to shake up new method of action. But with so many ppl having trypanophobia could find a nice niche if they can get it on shelves and have awareness.